Unchained Bio is a tech startup based in The Netherlands creating a cloud platform for protein patent "content modelling" in the immunotherapy and therapeutic antibody space.
A new cloud app from the company provides users an augmented view of patented proteins, allowing users to explore the "third dimension" of chemical and physical data that resides behind the printed words in the patent literature.
The team of four is mining the explosion in IP and patenting of therapeutic antibodies to enable a better understanding of biomolecules as a corner-stone for powerful therapies. The user inputs a patent number, and then receives a report with chemical properties and a 3D visualization of each protein sequence therein—all created with AI and computational modelling. It’s a bit like a cloud computational scientist on-demand, with a one-hour turn-around time and no expertise required.
To learn more, visit the Unchained Bio website at https://www.unchainedbio.com. The cloud app will launch in a couple of weeks. To test as an early adopter, contact email@example.com.